Advertisment

Ryaltris

Glenmark logo
Glenmark Pharmaceuticals on Friday announced approval by Health Canada for its nasal spray Ryaltris used in symptomatic treatment of moderate to severe seasonal allergic rhinitis
Advertisment
Subscribe